1. In Vivo
  2. >>Leadership
  3. >>Rising Leaders

AI Medical Technology: A Rising Leader, One Year Later

 
• By Barnaby Pickering

AI Medical Technology has been busy, with publications demonstrating its lead product’s potential in melanoma, ongoing fundraising and board appointments.  

AI MEDICAL TECHNOLOGY'S DERMALYSER AIMS TO GIVE DOCTORS MORE CONFIDENCE WHEN MAKING DECISIONS • Source: Shutterstock

Since being nominated as one of In Vivo’s rising leaders a year ago, Christoffer Ekström has overseen several key developments at his company, AI Medical Technology.

Lead Product 

AI Medical Technology’s lead product is its Dermalyser platform, which uses artificial intelligence to transform a smartphone into a powerful tool for the diagnosis of melanoma. A clinician uses dermalyser in conjunction with a dermatoscope placed in front of their smartphone camera. They take a picture of a lesion of concern, and Dermalyzer provides a diagnostic recommendation in just a few seconds.

2023 saw the appointment of two new board members to the company. Peter Löwendahl joined in March, and has been...

More from Rising Leaders

Rising leaders 2025: Aneesh Karatt-Vellatt On Maxion Therapeutics’ Antibody Revolution

 
• By Jo Shorthouse

Aneesh Karatt-Vellatt is leading the charge to redefine how ion channels and G protein-coupled receptors (GPCRs) are targeted with antibody therapies, one of the most notoriously challenging classes of drug targets.

Rising Leaders 2025: Abbas Kazimi’s Vision For Nimbus Therapeutics

 
• By David Wild

Rising Leader Abbas Kazimi's leadership at Nimbus Therapeutics combines immigrant resilience, patient-first partnerships, contrarian strategic bets and a deeply personal mission driving breakthrough drug discovery innovation.

Rising Leaders 2025: Regeneron’s Karen Rodriguez Lorenc On Not Believing In Failure

 
• By Jo Shorthouse

Karen Rodriguez Lorenc has overseen linvoseltamab's development and subsequent approvals in Europe and the US. She talked to In Vivo about how patient-centric drug development philosophy is core to her leadership, and why she doesn't believe in failure.

Rising Leaders 2025: Neha Krishnamohan On Readying For Uncertainty In Biotech

 
• By Meredith Landry

Neha Krishnamohan, CFO of Artiva Biotherapeutics, brings Wall Street precision to biotech innovation, helping lead the company through a successful IPO while advancing NK cell therapies for cancer and autoimmune diseases.

More from Leadership

Podcast: Oxolife’s Agnés Arbat, Winner Of The European Prize For Women Innovators

 
• By Jo Shorthouse

Agnès Arbat, CEO of Oxolife and winner of the EU Women Innovators Prize, joins In Vivo to discuss OXO-001, a novel non-hormonal treatment aimed at improving embryo implantation in IVF. She shares insights from her biotech journey and the future of fertility innovation.

Execs On The Move: June 2025

 
• By In Vivo Team

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Kris Joshi Named Norstella CEO, Prioritizes AI Innovation

 
• By Aakash Babu

Joshi joins the parent company of Citeline, which houses flagship publications In Vivo, Scrip and Pink Sheet, to focus on AI, business harmonization and long-term growth.